Thomas J Galloway MD

Head & Neck, Sarcoma, Skin Cancer

Assistant Professor, Director of Clinical Research

333 Coltman AvenueFox Chase Cancer CenterPhiladelphia, PA 19111
Phone+1 215-728-6900
Fax+1 215-214-1629

Dr. Galloway is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Galloway's full profile Already have an account?

Education & Training

University of FloridaResidency, Radiation Oncology, 2006 - 2010
MedStar Health Georgetown University/Georgetown HospitalInternship, Internal Medicine, 2005 - 2006
University of Florida College of MedicineClass of 2005
University of FloridaB.S., Major: Chemistry; Minors: Business Administration, History, 1997 - 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

PA State Medical License 2010 - 2026
VA State Medical License 2005 - 2006
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017

Clinical Trials

RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
ACTIVE_NOT_RECRUITING
PHASE3
TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. Start of enrollment: 2013 Mar 15
COMPLETED
PHASE2
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Start of enrollment: 2013 Mar 22
SUSPENDED
PHASE2, PHASE3

Publications & Presentations

PubMed

Quality of Life in Patients With p16+ Oropharyngeal Cancer Receiving Accelerated Radiation Therapy With Either Cisplatin or Cetuximab in the NRG/RTOG 1016 Randomized C...
Jolie Ringash, Pedro A Torres-Saavedra, Maura L Gillison, Jimmy J Caudell, David J Adelstein
International Journal of Radiation Oncology, Biology, Physics. 2026-09-01
Practices and Impressions of Head and Neck Cancer Multidisciplinary Tumor Boards Findings From an American Head and Neck Society Survey.
Christopher M K L Yao, Sydney Beatty, Flora Yan, Alex O Esemezie, Shao Hui Huang
Head & Neck. 2026-08-01
Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma.
Bina Kassamali, Jonathan D Schoenfeld, Rosh Sethi, Richard L Bakst, Christopher A Barker
JAMA Dermatology. 2026-07-08

Journal Articles

Evaluation and management of head and neck squamous cell carcinoma of unknown primary
Martin JM, Galloway TJ, Surgical Oncology Clinics of North America, 1/1/2015
A Phase 1 Study of CUDC-101, a multitarget inhibitor of HDACs, EGFR and HER2, in combination with chemoradiation in patients with head and neck squamous cell carcinoma
Galloway TJ, Wirth L, Colevas D, Gilbert J, Bauman J, Saba N, Raben D, Mehra R, Burtness B, Jimeno A, Clinical Cancer Research, 1/1/2015
Increasing time to treatment initiation for squamous cell carcinoma of the head and neck: An analysis of the National Cancer Database
Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder D, Ridge JA, Cancer, 1/1/2015

Books/Book Chapters

Cancer Management: A Multidisciplinary Approach
Chapter: Head and Neck Tumors.
Lango MN, Mehra R, Ridge JA, Galloway TJUBM Media, Norwalk, CTEdition 16th,2014
Radiation Oncology: Imaging and Treatment
Chapter: Larynx.
Galloway TJ, Amdur RJEditors: Gaffney DK.Amirsys, Salt Lake City2013

Abstracts/Posters

One size does not fit all-Evaluating the need for separate unilateral and bilateral radiotherapy normal tissue treatment planning goals for oropharynx cancer.
Wang L, Flanagan P, Gleason R, Murphy C, Churilla T, Galloway TJ, ASTRO, 1/1/2015
PreTreatment Tumor-Specific Growth Rate as a Temporal Biomarker that Predicts Treatment Failure and Improves Risk Stratification for Oropharyngeal Cancer.
Murphy CT, Devarajan K, Wang LS, Mehra R, Ridge JA, Fundakowski C, Galloway TJ, ASTRO, 1/1/2015
Symptom Reduction from IMRT Dose Deintensification: Results from ECOG 1308 Using the Vanderbilt Head and Neck Symptom Survey Version 2 (VHNSS V2).
Cmelak A, Li S, Marur S, Zhao W, Westra WH, Chung CH, Gillison ML, Gilbert J, Bauman JE, Wagner LI, Ferris RL, Trevarthen DR, Murphy BA, Galloway T, Burtness B, ASCO, 1/1/2015

Lectures

De-intensification for favorable risk oropharynx cancer – all are created equal?
University of Florida, Gainesville, FL - 1/27/2015
Trying to make sense of an Unknown Primary
University of Florida, Gainesville, FL - 1/21/2014
Predictive Value of p16 status on the development of a pathologic complete response (pCR) at planned neck dissection after cisplatin based chemoradiation - a second an...
San Francisco, CA - 1/1/2014

Other

Management and prevention of complications of head and neck cancer during initial treatment.
Galloway TJ, Amdur RJ; Basow DS (ed), UpToDate
Waltham, MA - 1/1/2015
Management of late complications of head and neck cancer and its treatment.
Galloway TJ, Amdur RJ; Basow DS (ed), UpToDate
Waltham, MA - 1/1/2015

Press Mentions

Certain Head and Neck Cancer Survivors at Greater Risk for Long-Term Gastrostomy Tube UseOctober 25th, 2022
Head & Neck Cancer: Your Questions Answered by Fox Chase Cancer CenterApril 13th, 2022
Many Throat Cancer Patients Can Skip Neck SurgerySeptember 17th, 2014